Live Breaking News & Updates on Obesity drug india

Stay informed with the latest breaking news from Obesity drug india on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Obesity drug india and stay connected to the pulse of your community

Obesity drug India: Lilly could launch obesity drug in India next year, CEO says

Eli Lilly plans to launch its obesity drug, tirzepatide, in India next year. The drug, also known as Mounjaro for diabetes and Zepbound for weight-loss in the U.S., may see authorized generic versions. CEO David Ricks emphasized the need for India to enhance patent protection and eliminate redundant policies to attract global drugmaker investments.

Denmark , Telangana , Andhra-pradesh , India , United-states , Danish , David-ricks , Eli-lilly , Reuters , Novo-nordisk , Obesity-drug-india , Obesity-drug